Comparative effectiveness of erenumab versus oral preventive medications among migraine patients: A US claims database study

• Main Authors: Stewart J Tepper (Author), Juanzhi Fang (Author), Lujia Zhou (Author), Pamela Vo (Author), Ahmad Abdrabboh (Author), Mrudula Glassberg (Author), Matias Ferraris (Author)
• Format: Book
• Published: SAGE Publishing, 2021-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Erenumab, a fully human monoclonal antibody targeting the calcitonin gene-related peptide pathway, was developed specifically for preventive treatment of migraine. Objective: To compare the real-world effectiveness of erenumab and non-specific oral migraine preventive medication (OMPM) o...